Filed: 5/10/2023ACC: 0000950123-23-004214
📋 What this filing means
PATIENT SQUARE CAPITAL LP filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $124.42M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$124.42M
Total AUM (reported)
22.65M
Total Shares
Allocation by class
COM$74.04M59.5%
SHS$50.38M40.5%
Portfolio Concentration
Top 3$124.42M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 22.65M
Sole
Full voting authority
22.65M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
EARGO INC
SOLEShares15.82M
TypeSH
Market value$74.04M
59.51%
Sole
15.82M
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares6.83M
TypeSH
Market value$50.38M
40.49%
Sole
6.83M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
EARGO INCSOLE | COM | 15.82M | SH | $74.04M 59.51% | 15.82M | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 6.83M | SH | $50.38M 40.49% | 6.83M | 0.00 | 0.00 |